Scibase
  • HOW IT WORKS
    • NEVISENSE 3.0
    • HOW TO MEASURE
    • HOW IT WORKS
    • THE EIS TECHNOLOGY
    • CLINICAL STUDIES
    • CLINICAL BENEFITS
    • RESEARCH MILESTONES
    • PUBLICATIONS
    • PATIENT LESION CARDS
  • FOR PATIENTS
    • SKIN CANCER INFORMATION
    • WHY NEVISENSE?
    • FIND CLINICS
    • SELF EXAMINATION
    • PATIENT ORGANIZATIONS
  • SCIBASE
    • ABOUT SCIBASE
    • AVAILABLE MARKETS
    • CAREERS
    • WE ARE SCIBASE
    • NEWS & EVENTS
    • CEO-LETTERS
    • AVAILABLE MATERIALS
    • FINANCIAL INFORMATION
    • CONTACT US
  • INVESTORS
  • The Nevisense product
    • How it works
    • How to measure
    • The EIS Technology
    • Clinical studies
    • Clinical benefits
    • Publications
    • Patient lesion cards
  • For patients
    • Skin cancer information
    • Why Nevisense?
    • Find clinics
    • Self examination
    • Patient organizations
  • Scibase
    • About Scibase
    • Available materials
    • We are Scibase
    • News and events
    • Contact us
    • Privacy and Cookie policy
    • Login
  • Investors
    • About Scibase
    • Press releases
    • Business model
    • Reports and presentations
    • Corporate Governance
    • Contact

Increased diagnostic accuracy in the detection of malignant melanoma

HOW IT WORKS

With Nevisense, SciBase has developed a method for improving accuracy in the diagnostic process in the detection of malignant melanoma

Nevisense 3.0

FIND CLINICS

Selection of the growing list of clinics offering Nevisense

Clinical benefits

The largest-ever prospective study in the detection of malignant melanoma

ORDER NEVISENSE

Find a Nevisense sales representative near you

“Nevisense has mainly two advantages: Firstly: less need for cutting. Second advantage from my point of view is a nearly 100% hit rate.”

Prof. Dr. Axel Hauschild, Kiel

"The number one advantage regarding Nevisense is that it backs up my decision and provides me with more certainty in whether or not to excise a lesion"

Dr. Isabel Gahlen, Ludwigsburg, Germany

"Despite their experience and the diagnostic aids available, the accurate detection of malignant melanoma remains a challenge for dermatologists"

Dr. Hjalmar Kurzen, Freising, Germany

QUIZ

Experience the benefits with Nevisense in our lesion quiz

News

Events

  • SciBase announces skin barrier testing collaboration with leading Swiss research center

    December 6, 2018

  • Clinical Guideline for Nevisense published in Germany

    November 19, 2018

  • The following people have been appointed as members of SciBase Holding’s election committee for the Annual General Meeting in 2019:

    November 5, 2018

  • Load more news...

    Coming events

  • 1-4 May
    50. DDG-Tagung, 2019
    Berlin City Cube, Germany
  • 15-17 Mar
    Dermatologische Praxis 2019
    Frankenthal, Germany
  • 1-5 Mar
    AAD 2019
    Washington, USA

    Recent events

  • 15-17 Feb
    Zertifieringskurs med. Tumortherapie 2019, Novotel
    Berlin, Germany
  • 18-23 Jan
    Winter Clinical Dermatology Conference 2019
    Grand Hyatt Kauai, Koloa, Hawaii
  • 17-19 Jan
    7th ESDO,
    Berlin, Germany
  • 7-9 Dec
    21st Annual Mount Sinai Winter Symposium
    Icahn School of Medicine at Mount Sinai, New York , USA
  • 18-21 Oct
    Fall Clinical Dermatology Conference
    Las Vegas, USA
  • 13-15 Sep
    26 Deutscher Hautkrebskongress (ADO)
    Stuttgart, Germany
  • 12-16 Sep
    27th EADV Congress
    Paris, France
  • 24-28 Jul
    26 Fortbildungswoche (FOBI)
    Munich, Germany
  • 14-16 Jun
    5th World Congress of Dermoscopy
    Thessaloniki, Greece
  • 9-11 Mar
    Dermatologische Praxis 2018
    Frankenthal, Germany
  • 16-20 Feb
    AAD Annual Meeting
    San Diego, USA
  • 18-20 Jan
    6th ESDO
    Berlin, Germany
  • Load more events...
  • The Nevisense product
    • How it works
    • How to measure
    • The EIS Technology
    • Clinical studies
    • Clinical benefits
    • Publications
    • Patient lesion cards
  • For patients
    • Skin cancer information
    • Why Nevisense?
    • Find clinics
    • Self examination
    • Patient organizations
  • Scibase
    • About Scibase
    • Available materials
    • We are Scibase
    • News and events
    • Contact us
    • Privacy and Cookie policy
    • Login
  • Investors
    • About Scibase
    • Press releases
    • Business model
    • Reports and presentations
    • Corporate Governance
    • Contact